Profiel
Carol A.
Salvadore worked as a Director at Rich Pharmaceuticals, Inc. from 2017 to 2019.
Prior to that, she worked as a Principal at Cogent Resources Ltd.
She holds a doctorate degree from Rutgers State University of New Jersey and an undergraduate degree from New York University.
Eerdere bekende functies van Carol A. Salvadore
| Bedrijven | Functie | Einde |
|---|---|---|
| RICH PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 24-06-2019 |
Cogent Resources Ltd.
 Cogent Resources Ltd. Insurance Brokers/ServicesFinance Cogent Resources Ltd. provides insurance services. The British company was founded in 1983 by Antony Andrew Barrow. Mark John Alexander Bishop has been the CEO of the private company since 1985. | Corporate Officer/Principal | - |
Opleiding van Carol A. Salvadore
| Rutgers State University of New Jersey | Doctorate Degree |
| New York University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Rich Pharmaceuticals, Inc.
 Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
Cogent Resources Ltd.
Cogent Resources Ltd. Insurance Brokers/ServicesFinance Cogent Resources Ltd. provides insurance services. The British company was founded in 1983 by Antony Andrew Barrow. Mark John Alexander Bishop has been the CEO of the private company since 1985. | Finance |
